Cited by 44Cardiovascular Syncope and Autonomic DisordersRenin-Angiotensin System StudiesHeart Rate Variability and Autonomic Control

Altered Systemic Hemodynamic and Baroreflex Response to Angiotensin II in Postural Tachycardia Syndrome

Open access
Mustafa, Hossam I., Raj, Satish R., Diedrich, André, Black, Bonnie K., Paranjape, Sachin Y., Dupont, William D., Williams, Gordon H., Biaggioni, Italo +1 more·2012·Circulation: Arrhythmia and Electrophysiology

Abstract

Background—: Postural tachycardia syndrome (POTS) is characterized by excessive orthostatic tachycardia and significant functional disability. We have previously found that patients with POTS have increases in plasma angiotensin II (Ang II) that are twice as high as healthy subjects despite normal blood pressures (BPs). In this study, we assess systemic and renal hemodynamic and functional responses to Ang II infusion in patients with POTS compared with healthy controls. Methods and Results—: Following a 3-day sodium-controlled diet, we infused Ang II (3 ng/kg per minute) for 1 hour in patients with POTS (n=15) and healthy controls (n=13) in the supine position. All study subjects were women with normal BP. Ages were similar for patients with POTS and controls (mean±SEM, 30±2 versus 26±1 years;P=0.11). We measured the changes from baseline mean arterial pressure, renal plasma flow, plasma renin activity, aldosterone, urine sodium, and baroreflex sensitivity in both groups. In response to Ang II infusion, patients with POTS had a blunted increase compared with controls in mean arterial pressure (10±1 versus 14±1 mm Hg,P=0.01) and diastolic BP (9±1 versus 13±1 mm Hg,P=0.01) but not systolic BP (13±2 versus 15±2 mm Hg,P=0.40). Renal plasma flow decreased similarly with Ang II infusion in patients with POTS versus controls (−166±20 versus −181±17 mL/min per 1.73 kg/m 2,P=0.58). Postinfusion, the decrease in plasma renin activity (−0.9±0.2 versus −0.6±0.2 ng/mL per hour,P=0.43) and the increase in aldosterone (17±1 versus 15±2 pg/mL,P=0.34) were similar in both groups. The decrease in urine sodium excretion was similar in patients with POTS and controls (−49±12 versus −60±16 mEq/g creatinine,P=0.55). The spontaneous baroreflex sensitivity at baseline was significantly lower in patients with POTS compared with controls (10.1±1.2 versus 16.8±1.5 ms/mm Hg,P=0.003), and it was further reduced with Ang II infusion. Conclusions—: Patients with POTS have blunted vasopressor response to Ang II and impaired baroreflex function. This impaired vasoconstrictive response might be exaggerated with upright posture and may contribute to the subsequent orthostatic tachycardia that is the hallmark of this disorder. Clinical Trial Registration—: URL:http://www.clinicaltrials.gov. Unique identifier: NCT00962949.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circep.111.965343

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • POTS patients have an attenuated hypertensive response to Ang-II versus healthy control subjects after infusion of a standardized dose of Ang-II.

    “This is supported by the finding that POTSpatients have an attenuated hypertensive response to Ang-II versus healthy control subjects after infusion of a standardized dose of Ang-II (38).”
  • A study by Mustafa et al. found blunted pressor responses to angiotensin II infusion in POTS with intact renal plasma flow, aldosterone secretion, and renal sodium reabsorption.

    “Blunted pressor responses to angiotensin II infusion were observed in POTS with intact renal plasma flow, aldosterone secretion, and renal sodium reabsorption.”

    From Postural tachycardia syndrome – Diagnosis, physiology, and prognosis (2018) · cites this paper as Mustafa et al., 2012

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 36

  1. Eriksson L, Fyhrquist F. Plasma renin activity following central infusion of angiotensin II and altered CSF sodium concentration in the conscious goat. Acta Physiol Scand. 1976;98:209 -216.
  2. Kaplan NM, Silah JG. The effect of angiotensin II on the blood pressure in humans with hypertensive disease. J Clin Invest. 1964;43: 659 -669.
  3. Stanley JR, Giammattei CE, Sheikh AU, Green JL, Zehnder T, Rose JC. Effects of chronic infusion of angiotensin II on renin and blood pressure in the late-gestation fetal sheep. Am J Obstet Gynecol. 1997; 176:931-937.
  4. Oelkers W, Belkien L, Baumann J, Meyland M. The effect of captopril on renin, angiotensin II, cortisol and aldosterone during ACTH-infusion in man. Clin Exp Hypertens. 1982;4:1505-1517.
  5. Broide J, Soferman R, Kivity S, Golander A, Dickstein G, Spirer Z, Weisman Y. Low-dose adrenocorticotropin test reveals impaired adrenal function in patients taking inhaled corticosteroids. J Clin Endocrinol Metab. 1995;80:1243-1246.
  6. Raj SR, Robertson D. Blood volume perturbations in the postural tachycardia syndrome. Am J Med Sci. 2007;334:57-60.
  7. Mustafa HI, Garland EM, Biaggioni I, Black BK, Dupont WD, Robertson D, Raj SR. Abnormalities of angiotensin regulation in postural tachycardia syndrome. Heart Rhythm. 2011;8:422-428.
  8. Fu Q, VanGundy TB, Shibata S, Auchus RJ, Williams GH, Levine BD. Menstrual cycle affects renal-adrenal and hemodynamic responses during prolonged standing in the postural orthostatic tachycardia syndrome. Hypertension. 2010;56:82-90.
  9. Schnurr E, Lahme W, Kuppers H. Measurement of renal clearance of inulin and PAH in the steady state without urine collection. Clin Nephrol. 1980;13:26 -29.
  10. Shoback DM, Williams GH, Moore TJ, Dluhy RG, Podolsky S, Hol- lenberg NK. Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension. J Clin Invest. 1983;72: 2115-2124.
  11. Senanayake PD, Moriguchi A, Kumagai H, Ganten D, Ferrario CM, Brosnihan KB. Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats. Peptides. 1994;15:919 -926.
  12. Nakamoto H, Ferrario CM, Fuller SB, Robaczewski DL, Winicov E, Dean RH. Angiotensin-(1-7) and nitric oxide interaction in renovascular hypertension. Hypertension. 1995;25:796 -802.
  13. Kohara K, Tabuchi Y, Senanayake P, Brosnihan KB, Ferrario CM. Reassessment of plasma angiotensins measurement: effects of protease inhibitors and sample handling procedures. Peptides. 1991;12: 1135-1141.
  14. Kohara K, Brosnihan KB, Chappell MC, Khosla MC, Ferrario CM. Angiotensin-(1-7). A member of circulating angiotensin peptides. Hypertension. 1991;17:131-138.
  15. Heart rate variability: standards of measurement, physiological interpre- tation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation. 1996;93:1043-1065.
  16. Persson PB, DiRienzo M, Castiglioni P, Cerutti C, Pagani M, Honzikova N, Akselrod S, Parati G. Time versus frequency domain techniques for assessing baroreflex sensitivity. J Hypertens. 2001;19:1699 -1705.
  17. Hollenberg NK, Chenitz WR, Adams DF, Williams GH. Reciprocal influence of salt intake on adrenal glomerulosa and renal vascular responses to angiotensin II in normal man. J Clin Invest. 1974;54: 34 -42.
  18. Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JA, Smith RD. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev. 1993;45: 205-251.
  19. Bartter FC, Pronove P, Gill JR Jr, MacCardle RC. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome. Am J Med. 1962;33:811-828.
  20. Chesley LC, Talledo E, Bohler CS, Zuspan FP. Vascular reactivity to angiotensin 2 and norepinephrine in pregnant and nonpregnant women. Am J Obstet Gynecol. 1965;91:837-842.
  21. Laragh JH, Cannon PJ, Bentzel CJ, Sicinski AM, Meltzer JI. Angio- tensin II, norepinephrine, and renal transport of electrolytes and water in normal man and in cirrhosis with ascites. J Clin Invest. 1963;42: 1179 -1192.
  22. Williams GH, Hollenberg NK, Braley LM. Influence of sodium intake on vascular and adrenal angiotensin II receptors. Endocrinology. 1976;98: 1343-1350.
  23. Newby DE, Masumori S, Johnston NR, Boon NA, Webb DJ. Endog- enous angiotensin II contributes to basal peripheral vascular tone in sodium deplete but not sodium replete man. Cardiovasc Res. 1997; 36:268 -275.
  24. Miller JW, Streeten DH. Vascular responsiveness to norepinephrine in sympathicotonic orthostatic intolerance. J Lab Clin Med. 1990;115: 549 -558.
  25. Broome M, Aneman A, Haney M, Haggmark S, Johansson G, Biber B. Angiotensin II mesenteric and renal vasoregulation: dissimilar modu- latory effects with nitroprusside. Acta Anaesthesiol Scand. 2000;44: 1238 -1245.
  26. Reilly PM, Bulkley GB. Vasoactive mediators and splanchnic perfusion. Crit Care Med. 1993;21:S55-S68.
  27. Stewart JM. Pooling in chronic orthostatic intolerance: arterial vasocon- strictive but not venous compliance defects. Circulation. 2002;105: 2274 -2281.
  28. Hall JE. Control of sodium excretion by angiotensin II: intrarenal mech- anisms and blood pressure regulation. Am J Physiol. 1986;250: R960 -R972.
  29. Ishizaka N, Alexander RW, Laursen JB, Kai H, Fukui T, Oppermann M, Lefkowitz RJ, Lyons PR, Griendling KK. G protein-coupled receptor kinase 5 in cultured vascular smooth muscle cells and rat aorta. Regulation by angiotensin II and hypertension. J Biol Chem. 1997;272:32482-32488.
  30. Iwai N, Inagami T. Regulation of the expression of the rat angiotensin II receptor mRNA. Biochem Biophys Res Commun. 1992;182:1094 -1099.
  31. Lassegue B, Alexander RW, Nickenig G, Clark M, Murphy TJ, Griendling KK. Angiotensin II down-regulates the vascular smooth muscle AT1 receptor by transcriptional and post-transcriptional mechanisms: evidence for homologous and heterologous regulation. Mol Pharmacol. 1995;48:601-609.
  32. Reck G, Beckerhoff R, Vetter W, Armbruster H, Siegenthaler W. Control of plasma aldosterone in normal man during upright posture. Klin Wochenschr. 1975;53:955-959.
  33. Vaile JC, Fletcher J, Littler WA, Coote JH, Townend JN. Angiotensin II modulates cardiovascular autonomic control in the absence of baroreflex loading. Heart. 1998;80:127-133.
  34. Brooks VL. Chronic infusion of angiotensin II resets baroreflex control of heart rate by an arterial pressure-independent mechanism. Hypertension. 1995;26:420 -424.
  35. Farquhar WB, Taylor JA, Darling SE, Chase KP, Freeman R. Abnormal baroreflex responses in patients with idiopathic orthostatic intolerance. Circulation. 2000;102:3086 -3091.
  36. Custaud MA, de Souza Neto EP, Abry P, Flandrin P, Millet C, Duvareille M, Fortrat JO, Gharib C. Orthostatic tolerance and spontaneous baro- reflex sensitivity in men versus women after 7 days of head-down bed rest. Auton Neurosci. 2002;100:66 -76.

Cited by

Sorted by citations

Authors
Mustafa, H. I., Raj, S. R., Diedrich, A., Black, B. K., Paranjape, S. Y., Dupont, W. D., Williams, G. H., Biaggioni, I., & Robertson, D.
Affiliations
Vanderbilt University (US)
Venue
Circulation: Arrhythmia and Electrophysiology
Published
2012-02
Volume
5
Issue
1
Pages
173-180
ISSN
  • 1941-3084 (ISSN-L)
  • 1941-3149
OpenAlex
W1976637622
Cited by
44
References
6
Citations by year
2025: 3 · 2024: 2 · 2023: 4 · 2022: 8 · 2021: 4 · 2020: 4 · 2019: 3 · 2018: 7 · 2017: 3 · 2016: 2 · 2015: 1 · 2014: 3
FWCI
1.30
Type
journal article
Language
en
Open access
Locations
  • Circulation Arrhythmia and Electrophysiology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Vanderbilt University
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute (R01HL071784, P01HL056693, R01HL102387)
  • National Institute of Neurological Disorders and Stroke (U54NS065736)
  • National Center for Research Resources (KL2RR024977, TL1RR024978, UL1RR024975, K23RR020783)
  • NIH Clinical Center
Topics
  • Health Sciences › Medicine › Surgery › Cardiovascular Syncope and Autonomic Disorders
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
Keywords
postural orthostatic tachycardia syndrome, angiotensin II, baroreflex sensitivity, systemic hemodynamics, renal plasma flow, plasma renin activity, aldosterone, sodium excretion, orthostatic tachycardia, autonomic dysfunction, plasma angiotensin II
MeSH terms
Adolescent, Adult, Angiotensin II, Dose-Response Relationship, Drug, Female, Follow-Up Studies, Hemodynamics, Humans, Infusions, Intravenous, Middle Aged, Retrospective Studies, Vasoconstrictor Agents, Treatment Outcome, Baroreflex, Postural Orthostatic Tachycardia Syndrome, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review